| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/12/2008 | US7410994 (6-methanesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-methanol; cyclooxygenase, prostaglandin G/H synthase inhibitors; antiinflammatory and analgesic agents; autoimmune diseases; Alzheimer's disease and osteoporosis of women after menopause |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410990 Heterocyclic compounds |
| 08/12/2008 | US7410987 Treating pruritus or pain, particularly that caused by a rheumatic disease, by administering a 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazoline, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410957 Method of treatment using bisphosphonic acid |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | CA2562918C Process for glucan preparation and therapeutic uses of glucan |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/07/2008 | WO2008093677A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 08/07/2008 | WO2008093674A1 Novel thiadiazole derivative having kinase inhibitory activity |
| 08/07/2008 | WO2008093236A1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/07/2008 | WO2008093227A1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/07/2008 | WO2008092894A1 Modulators of sclerostin binding partners for treating bone-related disorders |
| 08/07/2008 | WO2008092681A1 Ghrelin receptor modulators |
| 08/07/2008 | WO2008092591A2 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent |
| 08/07/2008 | WO2007140222A3 Pyrrolopyrimidine compounds and their uses |
| 08/07/2008 | WO2007068116A8 Method for correcting a lipid imbalance in a subject |
| 08/07/2008 | US20080188644 Polypeptide containing metal ions stimulates skeletal growth and inhibits bone resorption; nutraceutical for preventing and treating osteoporosis and rheumatoid or osteo-arthritis |
| 08/07/2008 | US20080188548 Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 08/07/2008 | US20080188459 antiinflammatory agents; side effects rduction; less toxicity, irritation, allergic response; rheumatoid arthritis, psoriasis, asthma, Crohn's disease, ulcerative colitis, COPD ; rel-N-[(2R,10,14b)-8-cyano-1,2,3,4,10,14b-hexahydro-10-methyldibenzo[c,f]pyrido[1,2-a]azepin-2-yl]-2,2,2-trifluoroacetamide |
| 08/07/2008 | US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188413 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080188401 Compounds |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187576 Osteoarthritis; rheumatic diseases; gene therapy; interleukin receptor antagonist peptide or polypeptide |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187544 Treating and evaluating inflammatory disorders |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080184618 Adsorbing, binding deactivated viruses; therap for mammals infections; gastrointestinal disorders |
| 08/07/2008 | CA2676163A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 08/07/2008 | CA2675639A1 Modulators of sclerostatin biniding partners for treating bone-related disorders |
| 08/06/2008 | EP1953165A1 Aza-substituted spiro derivative |
| 08/06/2008 | EP1953162A1 Xanthin derivatives, their production and utilisation as medicine |
| 08/06/2008 | EP1953148A1 Heterocyclic amide compound and use thereof |
| 08/06/2008 | EP1952818A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 08/06/2008 | EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 08/06/2008 | EP1951687A1 N-hydroxyamide derivatives and use thereof |
| 08/06/2008 | EP1951304A1 Method for treating joint damage |
| 08/06/2008 | EP1951265A2 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid |
| 08/06/2008 | EP1951261A2 Compositions and methods for treating inflammatory disorders |
| 08/06/2008 | EP1951218A1 Medicament for use in connection with cartilage impairment |
| 08/06/2008 | EP1951214A2 Modulation of osteoclast differentiation |
| 08/06/2008 | EP1951048A2 Flavanols and b-type procyanidins and inflammation |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1748785B1 Peptides for the modulation of cartilage homeostasis |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof |
| 08/06/2008 | CN101238127A Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 08/06/2008 | CN101237885A Agent for regeneration and/or protection of nerves |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101235097A Method for extracting polysaccharide from angelica and application thereof |
| 08/06/2008 | CN101235041A Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof |
| 08/06/2008 | CN101234189A Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) |
| 08/06/2008 | CN101234176A Method for preparing í«suhua powder medicine for treating hyperosteogenyí» |
| 08/06/2008 | CN101234158A Method for manufacturing 180 minutes bone fracture setting ointment without operation |
| 08/06/2008 | CN101234153A Externally-applied medicament for treating bone fracture |
| 08/06/2008 | CN101234152A Method for manufacturing quick-effective bone setting powder |
| 08/06/2008 | CN101234143A Method for preparing plaster for treating lumbar sprain disease |
| 08/06/2008 | CN101234090A Kukoline or its salts sustained-release microsphere and preparation thereof and sustained-release injection preparations |
| 08/06/2008 | CN101233885A Health tea |
| 08/06/2008 | CN100408581C 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 08/06/2008 | CN100408579C Xanthine derivative, production and use thereof as a medicament |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408086C Health product for resisting inflammation, stopping pain and promoting rehabilitation of articular cartilage |
| 08/06/2008 | CN100408073C Chinese patented medicine for treating lumber spinal canal stenosis |
| 08/06/2008 | CN100408055C Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method |
| 08/06/2008 | CN100408049C Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process |
| 08/06/2008 | CN100408048C Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof |
| 08/06/2008 | CN100408037C Medicine for treating osteomyelitis and preparation thereof |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407956 Benzamide inhibitors of the P2X7 receptor |
| 08/05/2008 | US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 08/05/2008 | CA2473718C Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/05/2008 | CA2290622C Selective thyroid hormone analogs |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 08/05/2008 | CA2111199C Pharmaceutical formulations of osteogenic proteins |
| 07/31/2008 | WO2008091043A1 A composition for prevention or treatment of bone marrow damage |
| 07/31/2008 | WO2008091013A1 Method for preparation of cartilage cell |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090360A1 Methods |
| 07/31/2008 | WO2008090334A1 Serotonin receptor antagonists for treating arthritis |